Abstract
Functional constipation is a common problem among children. The prevalence worldwide is about 3% and it is accounting for about 3–5% of all visits to pediatricians implicating a significant impact on health care cost. In most children presenting with the symptom constipation no underlying medical disease responsible for the symptom can be found; this is the so-called functional constipation. Functional constipation is characterized by infrequent bowel movements, hard and/or large stools, painful defecation, sometimes in combination with fecal incontinence, and is often accompanied by abdominal pain, without evidence of a structural or biochemical explanation.
The recommendation for the management of FC includes a normal intake of fibers and fluids, normal physical activity, and an additional pharmacologic treatment for fecal disimpaction followed by a pharmacologic maintenance therapy.
In infants constipation is treated somewhat differently as compared with children. When constipation presents early in life, the risk of an underlying organic disease is increased compared to older children.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bandla HP, Davis SH, Hopkins NE (1999) Lipoid pneumonia: a silent complication of mineral oil aspiration. Pediatrics 103:E19
Bekkali NL, van den Berg MM, Dijkgraaf MG et al (2009) Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG. Pediatrics 124:e1108–e1115
Borowitz SM, Cox DJ, Kovatchev B et al (2005) Treatment of childhood constipation by primary care physicians: efficacy and predictors of outcome. Pediatrics 115:873–877
Constipation Guideline Committee of the North American Society for Pediatric Gastroenterology H, Nutrition (2006) Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 43:e1–e13
Dehghani SM, Kulouee N, Honar N et al (2015) Clinical manifestations among children with chronic functional constipation. Middle East J Dig Dis 7:31–35
Farahmand F, Eftekhari K, Modarresi V et al (2010) Comparing oral route paraffin oil versus rectal route for disimpaction in children with chronic constipation; a randomized control trial. Iran J Pediatr 20:291–296
Friedrich C, Richter E, Trommeshauser D et al (2011) Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women. Drug Metab Pharmacokinet 26:458–464
Gattuso JM, Kamm MA (1994) Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf 10:47–65
Gleghorn EE, Heyman MB, Rudolph CD (1991) No-enema therapy for idiopathic constipation and encopresis. Clin Pediatr (Phila) 30:669–672
Gomes PB, Duarte MA, Melo Mdo C (2011) Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children. J Pediatr 87:24–28
Gomez R, Mousa H, Liem O et al (2010) How do antegrade enemas work? Colonic motility in response to administration of normal saline solution into the proximal colon. J Pediatr Gastroenterol Nutr 51:741–746
Gordon M, Naidoo K, Akobeng AK et al (2013) Cochrane review: osmotic and stimulant laxatives for the management of childhood constipation (Review). Evid Based Child Health 8:57–109
Hansen SE, Whitehill JL, Goto CS et al (2011) Safety and efficacy of milk and molasses enemas compared with sodium phosphate enemas for the treatment of constipation in a pediatric emergency department. Pediatr Emerg Care 27:1118–1120
Harrington L, Schuh S (1997) Complications of Fleet enema administration and suggested guidelines for use in the pediatric emergency department. Pediatr Emerg Care 13:225–226
Hoekman DR, Benninga MA (2013) Functional constipation in childhood: current pharmacotherapy and future perspectives. Expert Opin Pharmacother 14:41–51
Hyams JS, Di Lorenzo C, Saps M et al (2016) Functional disorders: children and adolescents. Gastroenterology. https://doi.org/10.1053/j.gastro.2016.02.015
Hyman PE, di Lorenzo C, Prestridge LL et al (2014) Lubiprostone for the treatment of functional constipation in children. J Pediatr Gastroenterol Nutr 58:283–291
Ismail EA, Al-Mutairi G, Al-Anzy H (2000) A fatal small dose of phosphate enema in a young child with no renal or gastrointestinal abnormality. J Pediatr Gastroenterol Nutr 30:220–221
Koppen IJ, Lammers LA, Benninga MA et al (2015) Management of functional constipation in children: therapy in practice. Paediatr Drugs 17:349–360
Lee-Robichaud H, Thomas K, Morgan J et al (2010) Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev 7:CD007570
Liem O, Harman J, Benninga M et al (2009) Health utilization and cost impact of childhood constipation in the United States. J Pediatr 154:258–262
Loening-Baucke V, Krishna R, Pashankar DS (2004) Polyethylene glycol 3,350 without electrolytes for the treatment of functional constipation in infants and toddlers. J Pediatr Gastroenterol Nutr 39:536–539
Manabe N, Cremonini F, Camilleri M et al (2009) Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers. Aliment Pharmacol Ther 30:930–936
Meier DE, Foster ME, Guzzetta PC et al (1998) Antegrade continent enema management of chronic fecal incontinence in children. J Pediatr Surg 33:1149–1151; discussion 1151–1142
Michail S, Gendy E, Preud'Homme D et al (2004) Polyethylene glycol for constipation in children younger than eighteen months old. J Pediatr Gastroenterol Nutr 39:197–199
Mugie SM, Korczowski B, Bodi P et al (2014) Prucalopride is no more effective than placebo for children with functional constipation. Gastroenterology 147:1285–1295.e1281
Nurko S, Zimmerman LA (2014) Evaluation and treatment of constipation in children and adolescents. Am Fam Physician 90:82–90
Pashankar DS (2005) Childhood constipation: evaluation and management. Clin Colon Rectal Surg 18:120–127
Pelham RW, Nix LC, Chavira RE et al (2008) Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects. Aliment Pharmacol Ther 28:256–265
Perkin JM (1977) Constipation in childhood: a controlled comparison between lactulose and standardized senna. Curr Med Res Opin 4:540–543
Philichi L (2018) Management of childhood functional constipation. J Pediatr Health Care 32:103–111
Plunkett A, Phillips CP, Beattie RM (2007) Management of chronic functional constipation in childhood. Paediatr Drugs 9:33–46
Rafati M, Karami H, Salehifar E et al (2011) Clinical efficacy and safety of polyethylene glycol 3350 versus liquid paraffin in the treatment of pediatric functional constipation. Daru 19:154–158
Roerig JL, Steffen KJ, Mitchell JE et al (2010) Laxative abuse: epidemiology, diagnosis and management. Drugs 70:1487–1503
Saneian H, Mostofizadeh N (2012) Comparing the efficacy of polyethylene glycol (PEG), magnesium hydroxide and lactulose in treatment of functional constipation in children. J Res Med Sci 7:145–149
Santos-Jasso KA, Arredondo-Garcia JL, Maza-Vallejos J et al (2017) Effectiveness of senna vs polyethylene glycol as laxative therapy in children with constipation related to anorectal malformation. J Pediatr Surg 52:84–88
Sari Gokay S, Celik T, Yusuf Sari M et al (2018) Urticaria as a rare side effect of polyethylene glycol-3350 in a child: case report. Acta Clin Croat 57:187–189
Schreiber CK, Stone AR (1999) Fatal hypernatremia associated with the antegrade continence enema procedure. J Urol 162:1433; discussion 1433–1434
Sharif F, Crushell E, O'Driscoll K et al (2001) Liquid paraffin: a reappraisal of its role in the treatment of constipation. Arch Dis Child 85:121–124
Sondheimer JM, Gervaise EP (1982) Lubricant versus laxative in the treatment of chronic functional constipation of children: a comparative study. J Pediatr Gastroenterol Nutr 1:223–226
Spiller HA, Winter ML, Weber JA et al (2003) Skin breakdown and blisters from senna-containing laxatives in young children. Ann Pharmacother 37:636–639
Tabbers MM, DiLorenzo C, Berger MY et al (2014) Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 58:258–274
Thompson WG, Longstreth GF, Drossman DA et al (1999) Functional bowel disorders and functional abdominal pain. Gut 45(Suppl 2):II43–II47
Tolia V, Lin CH, Elitsur Y (1993) A prospective randomized study with mineral oil and oral lavage solution for treatment of faecal impaction in children. Aliment Pharmacol Ther 7:523–529
van den Berg MM, Benninga MA, di Lorenzo C (2006) Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol 101:2401–2409
Wald A (2003) Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol 36:386–389
Weisman LE, Merenstein GB, Digirol M et al (1983) The effect of early meconium evacuation on early-onset hyperbilirubinemia. Am J Dis Child 137:666–668
Wenande E, Garvey LH (2016) Immediate-type hypersensitivity to polyethylene glycols: a review. Clin Exp Allergy 46:907–922
Youssef NN, Peters JM, Henderson W et al (2002) Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr 141:410–414
Zanetti G, Marchiori E, Gasparetto TD et al (2007) Lipoid pneumonia in children following aspiration of mineral oil used in the treatment of constipation: high-resolution CT findings in 17 patients. Pediatr Radiol 37:1135–1139
Zhang H, Henry WA, Chen LA et al (2015) Urticaria due to polyethylene glycol-3350 and electrolytes for oral solution in a patient with jejunal nodular lymphoid hyperplasia. Ann Gastroenterol 28:148–150
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Flemming, G. (2019). Chronic Functional Constipation in Infants and Children. In: Kiess, W., Schwab, M., van den Anker, J. (eds) Pediatric Pharmacotherapy . Handbook of Experimental Pharmacology, vol 261. Springer, Cham. https://doi.org/10.1007/164_2019_223
Download citation
DOI: https://doi.org/10.1007/164_2019_223
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-50493-9
Online ISBN: 978-3-030-50494-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)